Cannabinoid Receptor Type 1 in the Brain Regulates the Affective Component of Visceral Pain in Mice. (1st August 2018)

• Record Type: Journal Article
• Authors: Bajic, Danica; Monory, Krisztina; Conrad, Andrea; Maul, Christina; Schmid, Roland M.; Wotjak, Carsten T.; Stein-Thoeringer, Christoph K.
• Is Part Of: Neuroscience. Volume 384(2018)
• Page Start: 397
• Page End: 405
• Publication Date: 2018-08-01
• Subjects: ACC anterior cingulate cortex -- ACT abdominal constriction test -- AEA anandamide -- CB1 cannabinoid receptor type 1 -- CB1 cannabinoid receptor type 1 -- CNS central nervous system -- HPT hot-plate test -- ISH in situ hybridization -- KO knock-out -- MGS mouse grimacing score -- MGS mouse grimacing score -- mPFC medial prefrontal cortex -- THC tetrahydrocannabinol -- TRPV1 transient receptor potential vanilloid receptor type 1 -- WT wild-type; visceral pain -- cannabinoid receptor type 1 -- brain -- affective -- pancreatitis; Neurochemistry -- Periodicals; Neurophysiology -- Periodicals; Neurology -- Periodicals; Neurochimie -- Périodiques; Neurophysiologie -- Périodiques; Neurochemistry; Neurophysiology; Electronic journals; Periodicals; Electronic journals; 612.8
• DOI: 10.1016/j.neuroscience.2018.05.041
• Languages: English
• ISSNs: 0306-4522

Abstract

Highlights: CB1 deletion in cortical glutamatergic neurons revealed a major role of supraspinal CB1 in acute visceral nociception. Supraspinal CB1 predominantly modulates the affective component of visceral pain. CB1 has divergent roles in nociception depending on the nature of pain, e.g., heat vs. visceral nociceptive stimulus. Abstract: Endocannabinoids acting through cannabinoid receptor type 1 (CB1) are major modulators of peripheral somatic and visceral nociception. Although only partially studied, some evidence suggests a particular role of CB1 within the brain in nociceptive processes. As the endocannabinoid system regulates affect and emotional behaviors, we hypothesized that cerebral CB1 influences affective processing of visceral pain-related behaviors in laboratory animals. To study nocifensive responses modulated by supraspinal CB1, we used conditional knock-out mice lacking CB1 either in cortical glutamatergic neurons (Glu-CB1-KO), or in forebrain GABAergic neurons (GABA-CB1-KO), or in principal neurons of the forebrain (CaMK-CB1-KO). These mutant mice and mice treated with the CB1 antagonist SR141716 were tested for different pain-related behaviors. In an acetic acid-induced abdominal constriction test, supraspinal CB1 deletions did not affect nocifensive responses. In the cerulein-model of acute pancreatitis, mechanical allodynia or hyperalgesia were not changed, but Glu-CB1- and CaMK-CB1-KO mice showed significantly increased facial grimacing scores indicating increased affective responses to this noxious visceral stimulus. Similarly, these brain-specific CB1 KO mice also showed significantly changed thermal nociception in a hot-plate test. These results reveal a novel, and important role of CB1 expressed by cortical glutamatergic neurons in the affective component of visceral nociception.